Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Black Women's Perspectives on Seeking Social Support for Physical Activity: A Qualitative Study.

Behavioral medicine (Washington, D.C.)·2026
Same author

Predictors of Self-Care Behaviours Among Patients With Chronic Disease: A Multicountry Survey.

Nursing research and practice·2026
Same author

Plant-based diet quality and cardiometabolic biomarkers in pregnant U.S. women.

Nutrition and health·2026
Same author

Social and Environmental Determinants of Stroke Functional Outcome and Strategies to Reduce Inequities: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

A life course approach to cardiovascular disease prevention.

European journal of cardiovascular nursing·2026
Same author

Community-Based and Public Health Initiatives Drive Cardiovascular Disease Prevention.

European journal of cardiovascular nursing·2026
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: May 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Manejo de lípidos sanguíneos anormales: un enfoque colaborativo.

Barbara Fletcher, Kathy Berra, Phil Ades

    Circulation
    |November 16, 2005
    PubMed
    Resumen
    Este resumen es generado por máquina.

    El tratamiento de los lípidos sanguíneos anormales (LBA) requiere un enfoque multidisciplinario que involucre a varios expertos. Este modelo de atención colaborativa mejora los resultados de los pacientes y reduce los eventos cardiovasculares y cerebrovasculares.

    Más Videos Relacionados

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K

    Videos de Experimentos Relacionados

    Last Updated: May 3, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    14.8K
    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.5K

    Área de la Ciencia:

    • Cardiología Cardiología.
    • La medicina preventiva es la medicina preventiva de las enfermedades.
    • Salud Pública La salud pública.

    Sus antecedentes:

    • Las directrices actuales hacen hincapié en el logro de los objetivos de tratamiento de lípidos.
    • El manejo de lípidos sanguíneos anormales (LBA) es complejo, lo que requiere diversos conocimientos especializados de profesionales de la salud.
    • Se establece un modelo multidisciplinario de gestión de casos para ABL.

    Objetivo del estudio:

    • Describir un enfoque colaborativo y multidisciplinario para el manejo de lípidos sanguíneos anormales.
    • Para resaltar los componentes de la gestión integral de ABL.
    • Para subrayar el impacto de este enfoque en la salud cardiovascular y cerebrovascular.

    Principales métodos:

    • El estudio describe un modelo de atención colaborativa para ABL.
    • Este modelo integra estrategias de prevención primaria y secundaria.
    • Incluye intervenciones nutricionales, de ejercicio y farmacológicas, haciendo hincapié en la adherencia.

    Principales resultados:

    • El enfoque multidisciplinario abarca el cuidado de por vida.
    • Incorpora modificaciones en el estilo de vida y farmacoterapia.
    • La adherencia es un enfoque clave dentro de este modelo.

    Conclusiones:

    • Se recomienda la implementación de un enfoque multidisciplinario de gestión de casos para ABL.
    • Esta estrategia integral tiene como objetivo mejorar la adherencia del paciente y los resultados.
    • Se espera que el enfoque reduzca la morbilidad y mortalidad cardiovascular y cerebrovascular.